890900 | ALC-0315
6-((2-hexyldecanoyl)oxy)-N-(6-((2-hexyldecanoyl)oxy)hexyl)-N-(4-hydroxybutyl)hexan-1-aminium
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
ALC-0315
6-((2-hexyldecanoyl)oxy)-N-(6-((2-hexyldecanoyl)oxy)hexyl)-N-(4-hydroxybutyl)hexan-1-aminium
6-((2-hexyldecanoyl)oxy)-N-(6-((2-hexyldecanoyl)oxy)hexyl)-N-(4-hydroxybutyl)hexan-1-aminium, or ALC-0315, is a highly specialized ionizable lipid engineered for LNP drug delivery systems. As a critical component in mRNA-based vaccines and gene therapies, it plays a significant role in nucleic acid encapsulation, intracellular delivery, and endosomal escape.
ALC-0315 is a cornerstone of modern RNA-based medicine, designed to optimize the stability and bioavailability of mRNA, siRNA, and CRISPR-based therapeutics.
Applications
ALC-0315 is a fundamental LNP component in mRNA-based vaccines used to ensure efficient payload protection and delivery. ALC-0315 also enables targeted nucleic acid delivery with low toxicity and high transfection efficiency crucial for RNA therapeutics.
This cationic lipid also enhances CRISPR, siRNA, and antisense oligonucleotide transport to facilitate precise gene modulation. Additionally, it is driving the development of next-generation RNA therapeutics by supporting advancements in oncology, rare disease treatment, and personalized medicine.
Packaging
Avanti Research™ provides ALC-0315 in powder (25mg, 50mg, 100mg, 200mg, 500mg, and 1g), so you can rest assured that products of the highest purity advance your research and development.
Our products are consistently created under carefully controlled conditions and to the highest purity level to ensure dependable results in your research and development.
If your research requires GMP-grade lipids, we’ve got you covered. Visit Croda Pharma to explore their GMP-certified options for high-purity pharmaceutical offerings that meet the strictest regulatory requirements.
C48H95NO5
C 75.24%, H 12.50%, N 1.83%, O 10.44%
CAS Registry Number is a Registered Trademark of the American Chemical Society
Schoenmaker, Linde et al. “mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.” International journal of pharmaceutics vol. 601 (2021): 120586. doi:10.1016/j.ijpharm.2021.120586
PubMed ID: 33839230- Certificate of Analysis (Lot No. 890900O-1G-A-010 and 7049OQA010)
- Certificate of Analysis (Lot No. 890900O-200MG-A-010 and 7049ONA010)
- Certificate of Analysis (Lot No. 890900O-1G-B-010 and 7049OQB010)
- Certificate of Analysis (Lot No. 890900O-100MG-B-010 and 7049OLB010)
- Certificate of Analysis (Lot No. 890900O-50MG-B-010 and 7049OKB010)
- Certificate of Analysis (Lot No. 890900O-100MG-A-010 and 7049OLA010)
- Certificate of Analysis (Lot No. 890900O-25MG-A-010 and 7049OJA010)
- Certificate of Analysis (Lot No. 890900O-500MG-A-010 and 7049OPA010)
- Certificate of Analysis (Lot No. 890900O-25MG-B-011 and 7049OJB011)
- Certificate of Analysis (Lot No. 890900O-25MG-C-010 and 7049OJC010)
- Certificate of Analysis (Lot No. 890900O-50MG-C-010 and 7049OKC010)
- Certificate of Analysis (Lot No. 890900O-50MG-A-010 and 7049OKA010)
- Certificate of Analysis (Lot No. 890900O-1G-A-012 and 7049OQA012)
- Certificate of Analysis (Lot No. 890900O-1G-D-010 and 7049OQD010)
- Certificate of Analysis (Lot No. 890900O-1G-C-010 and 7049OQC010)
- Certificate of Analysis (Lot No. 890900O-200MG-B-010 and 7049ONB010)
- Certificate of Analysis (Lot No. 890900O-500MG-B-010 and 7049OPB010)
- Certificate of Analysis (Lot No. 890900O-200MG-A-011 and 7049ONA011)
- Certificate of Analysis (Lot No. 890900O-25MG-A-011 and 7049OJA011)
- Certificate of Analysis (Lot No. 890900O-100MG-A-011 and 7049OLA011)
- Certificate of Analysis (Lot No. 890900O-500MG-A-011 and 7049OPA011)
- Certificate of Analysis (Lot No. 890900O-50MG-A-011 and 7049OKA011)
- Certificate of Analysis (Lot No. 890900O-100MG-B-011 and 7049OLB011)
- Certificate of Analysis (Lot No. 890900O-200MG-B-011 and 7049ONB011)
- Certificate of Analysis (Lot No. 890900O-50MG-A-013 and 7049OKA013)
- Certificate of Analysis (Lot No. 890900O-500MG-A-013 and 7049OPA013)
- Certificate of Analysis (Lot No. 890900O-100MG-A-013 and 7049OLA013)
- Certificate of Analysis (Lot No. 890900O-50MG-B-013 and 7049OKB013)
- Certificate of Analysis (Lot No. 890900O-25MG-A-013 and 7049OJA013)
- Certificate of Analysis (Lot No. 890900O-200MG-A-013 and 7049ONA013)
- Certificate of Analysis (Lot No. 890900O-1G-B-013 and 7049OQB013)
- Certificate of Analysis (Lot No. 890900O-25MG-A-014 and 7049OJA014)
- Certificate of Analysis (Lot No. 890900O-100MG-A-014 and 7049OLA014)
- Certificate of Analysis (Lot No. 890900O-1G-A-014 and 7049OQA014)
- Certificate of Analysis (Lot No. 890900O-25MG-B-014 and 7049OJB014)
- Certificate of Analysis (Lot No. 890900O-200MG-A-014 and 7049ONA014)
- Certificate of Analysis (Lot No. 890900O-500MG-A-014 and 7049OPA014)
- Certificate of Analysis (Lot No. 890900O-100MG-B-014 and 7049OLB014)
- Certificate of Analysis (Lot No. 890900O-1G-A-016 and 7049OQA016)
- Certificate of Analysis (Lot No. 890900O-500MG-A-016 and 7049OPA016)
- Certificate of Analysis (Lot No. 890900O-25MG-A-015 and 7049OJA015)
- Certificate of Analysis (Lot No. 890900O-100MG-A-015 and 7049OLA015)
